Davita Kidney Care

The U.S. Supreme Court has overturned a lower court ruling on a lawsuit filed by DaVita Inc. against a hospital system in Ohio claiming its health plan discriminated against employees requiring dialysis care.

A federal grand jury on April 15 acquitted DaVita Inc. and its former CEO Kent Thiry of three counts of conspiracy based on coordinating agreements Thiry and the company arranged with three other companies not to solicit certain employees.

DaVita Kidney Care has appointed Mihran Naljayan, MD, as its new chief medical officer of home modalities, according to a press release.

DaVita Integrated Kidney Care has joined forces with more than 1,000 kidney doctors, transplant providers, hospice providers and advanced care practitioners to launch 11 value-based care programs across the U.S.

DaVita Inc. announced its acquired MedSleuth, a transplant software company known for connecting transplant candidates, transplant centers, physicians and care teams to improve kidney and liver transplant outcomes.

North American operations are now 100% powered by renewable energy, according to a press release.

DaVita Kidney Care has named Tina Livaudais as its new chief nursing officer; the announcement comes during Nephrology Nurses Week, a week designated by the American Nephrology Nurses Association to recognize members of the profession.

The COVID-19 pandemic led to a variety of changes in the nutritional care provided to patients receiving hemodialysis across the United States, according to results of a survey administered to 191 dialysis dieticians.

One of the challenges health care providers face in administering COVID-19 vaccines is vaccine hesitancy, especially among disadvantaged populations.

NephroSant, a startup operating out of the University of California, San Francisco that developed a test to detect graft rejection following kidney transplantation, has hired Gina Ford, RPh, MBA, as its new chief commercialization officer.